Novel methodologic approaches to phase I, II, and III trials.
作者信息
Yeatts Sharon D
机构信息
Department of Public Health Sciences, Medical University of South Carolina, 135 Cannon St, Charleston, SC 29425, USA.
出版信息
Stroke. 2013 Jun;44(6 Suppl 1):S116-8. doi: 10.1161/STROKEAHA.111.000031.
Abstract
摘要
相似文献
1
Novel methodologic approaches to phase I, II, and III trials.针对I期、II期和III期试验的新型方法学途径。
Stroke. 2013 Jun;44(6 Suppl 1):S116-8. doi: 10.1161/STROKEAHA.111.000031.
2
Novel endpoints and design of early clinical trials.早期临床试验的新型终点指标与设计
Ann Oncol. 2002;13 Suppl 4:139-43. doi: 10.1093/annonc/mdf651.
3
Applying a phase II futility study design to therapeutic stroke trials.将II期无效性研究设计应用于治疗性中风试验。
Stroke. 2005 Nov;36(11):2410-4. doi: 10.1161/01.STR.0000185718.26377.07. Epub 2005 Oct 13.
4
Reporting trends of outcome measures in phase II and phase III trials conducted in advanced-stage non-small-cell lung cancer.报告Ⅱ期和Ⅲ期临床试验中晚期非小细胞肺癌结局指标的趋势。
Lung. 2013 Aug;191(4):313-9. doi: 10.1007/s00408-013-9479-z. Epub 2013 May 30.
5
An overview of pharmacoepidemiology.药物流行病学概述。
Pharm World Sci. 1995 May 26;17(3):61-6. doi: 10.1007/BF01875433.
6
Statistical aspects of the TNK-S2B trial of tenecteplase versus alteplase in acute ischemic stroke: an efficient, dose-adaptive, seamless phase II/III design.替奈普酶与阿替普酶治疗急性缺血性脑卒中的 TNK-S2B 试验的统计学方面：一种高效、剂量适应、无缝的 II/III 期设计。
Clin Trials. 2011 Aug;8(4):398-407. doi: 10.1177/1740774511410582. Epub 2011 Jul 7.
7
The changing landscape of phase II/III metastatic NSCLC clinical trials and the importance of biomarker selection criteria.II/III 期转移性 NSCLC 临床试验格局的变化及生物标志物选择标准的重要性。
Cancer. 2014 Dec 15;120(24):3853-8. doi: 10.1002/cncr.28956. Epub 2014 Aug 25.
8
Trial watch: phase II and phase III attrition rates 2011-2012.试验观察：2011 - 2012年II期和III期损耗率
Nat Rev Drug Discov. 2013 Aug;12(8):569. doi: 10.1038/nrd4090.
9
Point: Intraperitoneal chemotherapy in the management of ovarian cancer.观点：腹腔内化疗在卵巢癌治疗中的应用
J Natl Compr Canc Netw. 2004 Nov;2(6):549-54. doi: 10.6004/jnccn.2004.0045.
10
Women in early-phase clinical drug trials: have things changed over the past 20 years?早期临床药物试验中的女性：在过去20年里情况有变化吗？
Clin Pharmacol Ther. 2005 Nov;78(5):445-52. doi: 10.1016/j.clpt.2005.08.016.
引用本文的文献
1
Early Intravenous Beta-Blockade with Esmolol in Adults with Severe Traumatic Brain Injury (EBB-TBI): Protocol for a Phase 2a Intervention Design Study.早期静脉注射艾司洛尔治疗成人严重创伤性脑损伤（EBB-TBI）：一项 2a 期干预设计研究方案。
Neurocrit Care. 2024 Apr;40(2):795-806. doi: 10.1007/s12028-023-01755-9. Epub 2023 Jun 12.
2
Optimizing a Bayesian hierarchical adaptive platform trial design for stroke patients.优化用于中风患者的贝叶斯分层自适应平台试验设计。
Trials. 2022 Sep 6;23(1):754. doi: 10.1186/s13063-022-06664-4.
3
Lessons Learned from Phase II and Phase III Trials Investigating Therapeutic Agents for Cerebral Ischemia Associated with Aneurysmal Subarachnoid Hemorrhage.从针对与颅内动脉瘤性蛛网膜下腔出血相关的脑缺血的治疗药物的 II 期和 III 期试验中吸取的经验教训。
Neurocrit Care. 2022 Apr;36(2):662-681. doi: 10.1007/s12028-021-01372-4. Epub 2021 Dec 23.
4
Assessment of various continual reassessment method models for dose-escalation phase 1 oncology clinical trials: using real clinical data and simulation studies.评估肿瘤 1 期临床试验剂量递增阶段的各种连续再评估方法模型：使用真实临床数据和模拟研究。
BMC Cancer. 2021 Jan 5;21(1):7. doi: 10.1186/s12885-020-07703-6.
5
A trial of buspirone for anxiety in Parkinson's disease: Safety and tolerability.帕金森病伴发焦虑的丁螺环酮治疗试验：安全性和耐受性。
Parkinsonism Relat Disord. 2020 Dec;81:69-74. doi: 10.1016/j.parkreldis.2020.10.020. Epub 2020 Oct 13.
6
Erlotinib for advanced hepatocellular carcinoma. A systematic review of phase II/III clinical trials.厄洛替尼用于晚期肝细胞癌。II/III期临床试验的系统评价
Saudi Med J. 2016 Nov;37(11):1184-1190. doi: 10.15537/smj.2016.11.16267.
7
Continual reassessment method for dose escalation clinical trials in oncology: a comparison of prior skeleton approaches using AZD3514 data.肿瘤学剂量递增临床试验的连续重新评估方法：使用AZD3514数据对先前框架方法的比较
BMC Cancer. 2016 Aug 31;16(1):703. doi: 10.1186/s12885-016-2702-6.
8
The futility study--Progress over the last decade.无效性研究——过去十年的进展。
Contemp Clin Trials. 2015 Nov;45(Pt A):69-75. doi: 10.1016/j.cct.2015.06.013. Epub 2015 Jun 26.
9
Combination Therapies for Traumatic Brain Injury: Retrospective Considerations.创伤性脑损伤的联合治疗：回顾性思考
J Neurotrauma. 2016 Jan 1;33(1):101-12. doi: 10.1089/neu.2014.3855. Epub 2015 Aug 6.
本文引用的文献
1
The neurology quality-of-life measurement initiative.神经病学生活质量测量倡议。
Arch Phys Med Rehabil. 2011 Oct;92(10 Suppl):S28-36. doi: 10.1016/j.apmr.2011.01.025.
2
Optimal end points for acute stroke therapy trials: best ways to measure treatment effects of drugs and devices.急性脑卒中治疗试验的最佳终点：评估药物和器械治疗效果的最佳方法。
Stroke. 2011 Aug;42(8):2356-62. doi: 10.1161/STROKEAHA.111.619122. Epub 2011 Jun 30.
3
Novel end point analytic techniques and interpreting shifts across the entire range of outcome scales in acute stroke trials.急性卒中试验中新型终点分析技术及解读整个结局量表范围内的变化
Stroke. 2007 Nov;38(11):3055-62. doi: 10.1161/STROKEAHA.107.488536. Epub 2007 Oct 4.
4
The Interventional Management of Stroke (IMS) II Study.卒中的介入治疗（IMS）II研究
Stroke. 2007 Jul;38(7):2127-35. doi: 10.1161/STROKEAHA.107.483131. Epub 2007 May 24.
5
A two-stage design for a phase II clinical trial of coenzyme Q10 in ALS.一项关于辅酶Q10在肌萎缩侧索硬化症（ALS）中的II期临床试验的两阶段设计。
Neurology. 2006 Mar 14;66(5):660-3. doi: 10.1212/01.wnl.0000201182.60750.66.
6
The promise of PROMIS: using item response theory to improve assessment of patient-reported outcomes.患者报告结果测量信息系统（PROMIS）的前景：运用项目反应理论改进患者报告结果的评估
Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S53-7.
7
Applying a phase II futility study design to therapeutic stroke trials.将II期无效性研究设计应用于治疗性中风试验。
Stroke. 2005 Nov;36(11):2410-4. doi: 10.1161/01.STR.0000185718.26377.07. Epub 2005 Oct 13.
8
Enhancing the development and approval of acute stroke therapies: Stroke Therapy Academic Industry roundtable.加强急性中风治疗方法的研发与审批：中风治疗学术产业圆桌会议
Stroke. 2005 Aug;36(8):1808-13. doi: 10.1161/01.STR.0000173403.60553.27. Epub 2005 Jul 14.
9
Measuring outcomes as a function of baseline severity of ischemic stroke.将缺血性中风的结局作为基线严重程度的函数进行测量。
Cerebrovasc Dis. 2004;18(2):124-9. doi: 10.1159/000079260. Epub 2004 Jun 22.
10
Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study.急性缺血性卒中的静脉与动脉联合再通治疗：卒中的介入管理研究
Stroke. 2004 Apr;35(4):904-11. doi: 10.1161/01.STR.0000121641.77121.98. Epub 2004 Mar 11.
Zotero 插件